Synergistic Chemotherapy Drug Response Is a Genetic Trait in Lymphoblastoid Cell Lines

Frontiers in Genetics - Switzerland
doi 10.3389/fgene.2019.00829
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Discovery of Genetic Biomarkers Contributing to Variation in Drug Response of Cytidine Analogues Using Human Lymphoblastoid Cell Lines

BMC Genomics
BiotechnologyGenetics
2014English

Heritable and Non-Genetic Factors as Variables of Pharmacologic Phenotypes in Lymphoblastoid Cell Lines

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2010English

Drug-Induced Apoptosis Is Delayed and Reduced in XPD Lymphoblastoid Cell Lines: Possible Role of TFIIH in P53-Mediated Apoptotic Cell Death

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Lymphoblastoid Cell Lines in Pharmacogenomic Discovery and Clinical Translation

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2012English

Chromosome Positioning Is Largely Unaffected in Lymphoblastoid Cell Lines Containing Emerin or A-Type Lamin Mutations

Biochemical Society Transactions
Biochemistry
2005English

A Synergistic Interaction Between Lapatinib and Chemotherapy Agents in a Panel of Cell Lines Is Due to the Inhibition of the Efflux Pump BCRP

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Interaction of Avian Reovirus With Chicken Lymphoblastoid Cell Lines

Avian Pathology
Animal ScienceZoologyFood AnimalsImmunologyMicrobiology
1994English

Drug Sensitivity in Cancer Cell Lines Is Not Tissue-Specific

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Transcript Isoform Variation Associated With Cytosine Modification in Human Lymphoblastoid Cell Lines

Genetics
Genetics
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy